We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BK:NYSEThe Bank of New York Mellon Corporation Analysis

Data as of 2026-05-30 - not real-time

$137.16

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Bank of New York Mellon (BK) is trading above its 20‑day (≈$135.7) and 50‑day (≈$130.2) simple moving averages, with the 200‑day SMA (≈$116.9) providing a strong long‑term floor. The RSI at 63.6 indicates continued upward momentum without being overbought, while a bullish MACD histogram (+0.18) confirms the trend. Price action sits comfortably between a near‑term support of $130.16 and resistance around $141.65, and the recent price rally aligns with an “Extreme Greed” sentiment (Fear‑Greed Index 94). Fundamentals reinforce the technical picture: revenue is up 13.4% YoY, operating margin sits near 38%, and ROE is 13.5%, all while the company maintains a modest payout ratio of 25% and a dividend yield of 1.53%, suggesting dividend sustainability. The PE of 17.0 is only marginally above the industry average of 16.6, and the beta of 0.85 points to lower volatility than the broader market, though 30‑day volatility of 16.5% remains noteworthy. A material development is the announced ticker change from “BK” to “BNY,” which could introduce short‑term trading noise but does not alter the underlying business outlook.
Overall, BK appears fairly valued with a blend of growth and value characteristics. The combination of solid cash reserves, low leverage, and consistent earnings growth supports a bullish stance for medium‑ to long‑term investors, while the technical setup and dividend profile add an extra layer of appeal for income‑focused traders.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (RSI, MACD, SMA alignment)
  • Support level at $130.16 offering downside cushion
  • Potential volatility from upcoming ticker symbol change

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth (13.4% YoY) and operating margin (~38%)
  • Sustainable dividend with low payout ratio
  • Robust balance sheet with ample cash and low beta

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Stable cash generation and low leverage supporting resilience
  • Consistent earnings growth and solid ROE
  • Industry positioning as a diversified bank with global client base

Key Metrics & Analysis

Financial Health

Revenue Growth13.40%
Profit Margin28.72%
P/E Ratio17.0
ROE13.47%
ROA1.20%
P/B Ratio2.4
Op. Cash Flow$3.3B
Industry P/E16.6

Technical Analysis

TrendBullish
RSI63.6
Support$130.16
Resistance$141.65
MA 20$135.69
MA 50$130.22
MA 200$116.91
MACDBullish
VolumeStable
Fear & Greed Index94.07

Valuation

Target Price$142.64
GradeFair
TypeBlend
Dividend Yield1.53%

Risk Assessment

Beta0.85
Volatility16.46%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.